SARS-CoV-2 ISO13485 Rapid Neutralizing Antibody Test Kit 96.6%

For professional and in vitro diagnostic use only.

For professional and in vitro diagnostic use only.

Product Feature

• Fast Test, get antigen test result within 10-15 minutes.
• High sensitivity and specificity
• Easy to operate, no need equipment, convenient and fast
• Require little Specimens

[PERFORMANCE CHARACTERISTICS]

Sensitivity

The sensitivity to S-mIgG1 neutralizing antibody can reach 2ug/mL.

Accuracy

A side-by-side comparison was conducted by the results of SARS-Cov-2 Neutralizing Antibody Test Device (Test Reagent) developed by Hangzhou Deangel Biological Engineering Co., Ltd. and cPass^TM from Genscript CO., Ltd. 328 clinical specimens from Professional Point of Care site were evaluated, 105 were positive and others negative. Base on the results from the clinical studies, the statistical analysis was made as follows:

For test reagent, the clinical sensitivity with the “Compared Reagent” was 91.4% (95% CI: 77.7%~100%), the clinical specificity was 99.1% (95% CI: 97.2%~100%), the coincidence rate was 96.6% (95% CI: 92.4%~100%).

[SUMMARY]

The novel coronaviruses belong to the β genus. COVID-19 is an acute respiratory infectious disease. People are generally susceptible. Currently, the patients infected by the novel coronavirus are the main source of infection; asymptomatic infected people can also be an infectious source. Based on the current epidemiological investigation, the incubation period is 1 to 14 days, mostly 3 to 7 days. The main manifestations include fever, fatigue and dry cough. Nasal congestion, runny nose, sore throat, myalgia and diarrhea are found in a few cases.

96.6% Neutralizing Antibody Rapid Test Kit

ISO13485 Neutralizing Antibody Rapid Test Kit

Antibody Rapid Test Kit SARS-CoV-2

ISO13485 96.6% Neutralizing Antibody Rapid Test Kit SARS-CoV-2 Images